Universal Influenza Virus Neuraminidase Vaccine Elicits Protective Immune Responses against Human Seasonal and Pre-pandemic Strains-Reference-Cited by-同舟云学术

Universal Influenza Virus Neuraminidase Vaccine Elicits Protective Immune Responses against Human Seasonal and Pre-pandemic Strains

Published:2021-08-10 Issue:17 Volume:95 Page:
ISSN:0022-538X
Container-title:Journal of Virology
language:en
Short-container-title:J Virol

Author:

Skarlupka Amanda L.¹,Bebin-Blackwell Anne-Gaelle¹,Sumner Spencer F.¹,Ross Ted M.¹²^ORCID

Affiliation:

1. Center for Vaccines and Immunology, University of Georgia, Athens, Georgia, USA

2. Department of Infectious Diseases, University of Georgia, Athens, Georgia, USA

Abstract

The development and distribution of a universal influenza vaccine would alleviate global economic and public health stress from annual influenza virus outbreaks. The influenza virus NA vaccine antigen allows for protection from multiple HA subtypes and virus host origins, but it has not been the focus of vaccine development.

Funder

Georgia Research Alliance

HHS | National Institutes of Health

University of Georgia

Publisher

American Society for Microbiology

Subject

Virology,Insect Science,Immunology,Microbiology

Link

https://journals.asm.org/doi/pdf/10.1128/JVI.00759-21

Reference72 articles.

1. Structural Basis of Protection against H7N9 Influenza Virus by Human Anti-N9 Neuraminidase Antibodies